Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
Children who start smoking prior to age 15 have a 27% increased risk of developing chronic obstructive pulmonary disease ( COPD) as adults, compared to those who started smoking later, researchers ...
Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
While wildfires can cause immediate destruction to homes and towns, a few weeks of smoke exposure should not have long-term ...
1d
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.
Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...
Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...
Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback